Diabetes is on the rise in children and young people

Published Date: 10 Mar 2023

New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...

Read Full News

Latest News

Faricimab Reduces Shots, Improves Vision for Retinal Disease

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Food Addiction Can Derail Success After Bariatric Surgery

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower physical activity, and less favorable weight-loss outcomes.

Will Semaglutide Prices Drop After 2026 Patent Expirations?

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Helping Patients With Diabetes Utilize Technology

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.

Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

Global Trial to Test Lifestyle Plus Metabolic Tx in Dementia

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower physical activity, and less favorable weight-loss outcomes.

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

News All Time

Managing Diabetes and HIV Together: What to Know

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, requiring specialized management approaches.

GLP-1s May Reduce Overdose Risk, Even After Discontinuation

People with a history of alcohol, opioid, or substance overdose who are later started on GLP-1 medications have a significantly lower risk for a repeat overdose.

South Africa's IDexis Appeals Court Ruling Over Compounded Weight-loss Drugs

South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production ⁠of compounded weight-loss medicines, disputing...

Study Flags Need to Monitor Frailty Risks With GLP-1 Drugs for Older Adults

Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study...

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated ⁠by injections, which could potentially broaden the use...

Do Infant Food Portion Sizes Matter for Later Overweight?

Larger food portions during complementary feeding are associated with higher odds of overweight in both early and later childhood.

Semaglutide Linked to Rare Brain Illness

In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional intake, and rapid weight loss leading to thiamine deficiency.

Screening for Diabetes at Urgent Care Could Save Lives

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures.

Women Wait Longer Than Men for a Thyroid Disease Diagnosis

Some symptoms of hypothyroidism and hyperthyroidism overlap with those of other conditions and diseases, which makes differential diagnosis challenging.

Two Dietary Fibers May Cut Crohn’s Risk in Certain Patients

Eating more dietary fibers such as beta-glucan and inulin is linked to a lower risk for Crohn’s disease in first-degree relatives of patients with Crohn’s disease.

Androgen Blood Test May Help Diagnose Endometriosis

Women with endometriosis show a distinct blood androgen profile that distinguishes them from women without the disease, pointing to a possible future noninvasive test.

Ovarian Cancer: Can Repurposed Drugs Work Better Together?

A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

First Non-Hormonal Menopause Drug Approved in Scotland

The Scottish Medicines Consortium has accepted fezolinetant for restricted use within NHS Scotland for menopausal vasomotor symptoms in women who cannot take hormone therapy.

Acromegaly Tied to Elevated Colorectal, Thyroid Cancer Risk

Acromegaly is tied to a higher risk for colorectal cancer and benign colorectal lesions, but the overall long-term cancer risk and cancer-related mortality remain comparable to the general population.

Guidance Aids Adjunctive Incretin Use in Type 1 Diabetes

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians with off-label prescribing.

Can Sniffing Chocolate Boost Leg Workout Performance?

Sniffing chocolate before performing sets of leg extensions may modulate appetite and increase overall training volume without raising perceived exertion.

Recommended News For You

An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

New First-Line Option for Advanced ALK-Positive Lung Cancer

Early breast cancer detection may be possible with a wearable ultrasound scanner.

Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests

When it comes to obesity-related cancers, where you shop for food matters

King Charles' Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer?

Recommended Articles For You

AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies 

Erythrocyte Functional Impairment During Critical Illness: Mechanisms, Clinical Implications, and Management 

Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes 

Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer

2.

Older Adults With Advanced Cancer Prioritize Quality of Life

3.

Higher levels of HIF2α found to slow down aggressive childhood cancer

4.

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

5.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

1.

Exploring the Role of Fecal Leukocytes in Intestinal Health

2.

Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment

3.

Iron Chelation Therapy: Preventing Long-Term Treatment Toxicities

4.

How to Manage Dic with the Right Treatment Approach

5.

Emerging Trends in Oncology for Modern Medicine

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

2.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

4.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

5.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot